The U.S. Drug Enforcement Agency (DEA) announced on Jan. 16, 2025, three new rules intended to implement patient protections and permanently ...

Despite the removal of the X-waiver requirement, which once restricted clinicians from prescribing buprenorphine for opioid ...

Rodman & Renshaw initiated coverage on shares of Indivior (NASDAQ: INDV) with a positive outlook, assigning a Buy rating and setting a price target of $16.00. The firm's analysts see Indivior as a ...

Around two-thirds of people relapse within 30 days after being discharged from residential treatment. An app could help them ...

The opioid crisis has touched nearly every demographic in our society. One area that doesn’t get enough attention is the toll ...

Montana Attorney General Austin Knudsen announced Montana will receive over $16 million from a settlemtn with Purdue Pharma ...

Despite the removal of the X-waiver requirement, which once restricted clinicians from prescribing buprenorphine for opioid use disorder (OUD), only a small percentage of primary care clinicians ...

Spokane County is considering expanding its opioid response by $650,000 after one program recently saw a roughly 85% success ...

Pat George, chairman of the Kansas Fights Addiction Act Grant Review Board, gives an update to the Senate Ways and Means ...

Last week, members of the Sackler family, which owns the pharmaceutical company known for selling OxyContin, agreed to a $7.4 ...

The Washoe County Sheriff’s Office, in collaboration with NaphCare, Inc., has announced the expansion of its ...

The Robert C. Byrd Clinic (RCBC) announced the launch of a new rural community health initiative. According to a press ...